Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) is trading higher after the company announced the opening of an investigator-sponsored trial (IST) of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE